In this sense, studies from our research group conclude that MLT decreases intestinal dysbiosis in mice with experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis, through the decrease of LPS and its binding protein (LBP) (Escribano et al. 2022). This evidence concerns the gene LBP and multiple sclerosis.